Equifax (EFX) CFO sells 2,500 shares at $208.37 under 10b5-1

Equifax Inc. (EFX) reported an insider transaction by its EVP, CFO & COO on a Form 4.

Accepted by SEC EDGAR 11/21/2025 - 04:07 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Equifax Inc. (EFX) reported an insider transaction by its EVP, CFO & COO on a Form 4. On 11/20/2025, the executive sold 2,500 shares of Equifax common stock at a price of $208.37 per share in an open-market sale coded as "S." The filing notes that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on 5/14/2025, which is designed to systematically execute trades. Following this transaction, the executive beneficially owned 59,527 shares of Equifax common stock directly.

Insider Trade Summary

Net Seller: 2,500 shares

Net Sell 1 txn

Insider GAMBLE JOHN W JR

Role EVP, CFO & COO

Sold 2,500 shs ($521K)

Share of Position Sold 4.0%

Type	Security	Shares	Price	Value
Sale	Common Stock	2,500	$208.37	$521K

Holdings After Transaction: Common Stock — 59,527 shares (Direct)

Holdings Before and After: Common Stock, 62,027 to 59,527 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/14/2025.
2. F2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Equifax (EFX) report in this Form 4?

The filing reports that Equifax's EVP, CFO & COO sold 2,500 shares of Equifax common stock on 11/20/2025 in an open-market transaction coded as "S."

At what price were the Equifax (EFX) shares sold by the EVP, CFO & COO?

The executive sold 2,500 shares of Equifax common stock at a price of $208.37 per share.

How many Equifax (EFX) shares does the executive own after the reported sale?

After the reported transaction, the EVP, CFO & COO beneficially owned 59,527 shares of Equifax common stock directly.

Was the Equifax (EFX) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on 5/14/2025.

What is the role of the reporting person in Equifax (EFX)?

The reporting person is an officer of Equifax, serving as EVP, CFO & COO.

Does the Form 4 mention dividend equivalent units for the Equifax (EFX) executive?

Yes. The filing notes that the reported holdings include accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the company's last dividend payment date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GAMBLE JOHN W JR

(Last) (First) (Middle)

1550 PEACHTREE STREET, N.W.

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO & COO

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/20/2025		S(1)		2,500	D	$208.37	59,527(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/14/2025.

2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

	/s/Lisa Stockard as Attorney-in-Fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.